<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00452894</url>
  </required_header>
  <id_info>
    <org_study_id>A3051076</org_study_id>
    <nct_id>NCT00452894</nct_id>
  </id_info>
  <brief_title>Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers</brief_title>
  <official_title>A Pharmacokinetic, Toleration And Safety Study Of Single And Multiple Oral Doses Of Varenicline In Chinese Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <brief_summary>
    <textblock>
      This study is to measure how much of varenicline tartrate is in Chinese healthy smokers'
      blood and urine after taking a single dose and several doses respectively, and also to test
      the safety (the impact of the study drug on Chinese healthy smokers' body) of varenicline.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The PK parameters after a single dose and PK parameters after 7 days of multiple dosing respectively.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>To gather safety data from Day 0 to Day 17 of the study.</measure>
  </secondary_outcome>
  <enrollment>14</enrollment>
  <condition>Smoking</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>varenicline tartrate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male and/or female Chinese subjects between the ages of 18 and 45 years,
             inclusive.

          -  Body Mass Index (BMI) of approximately 19 to 24 kg/m2; and a total body weight â‰¥50 kg.

          -  Individuals who have smoked an average of at least 10 cigarettes per day during the
             past year, with no period of abstinence greater than 3 months in the past year.

        Exclusion Criteria:

          -  Heart rate&gt;100 bpm, QRS Interval&gt;120 msec, QTc Interval &gt;430 msec, PR Interval&gt;220
             msec, or any other abnormalities observed on the Electrocardiogram.

          -  Subjects with a sitting blood pressure of 140/90 mmHg or above at screening.

          -  Subjects with evidence or history of clinically significant allergic, hematological,
             renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric or
             neurological disease, or any condition possibly affecting drug absorption.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3051076&amp;StudyName=Phase+1+Clinical+Trial+of+Varenicline+in+Chinese+Healthy+Smoking+Volunteers+</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2007</study_first_submitted>
  <study_first_submitted_qc>March 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2007</study_first_posted>
  <last_update_submitted>March 28, 2008</last_update_submitted>
  <last_update_submitted_qc>March 28, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2008</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varenicline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

